Psychedelics at Psych Congress 2026
4 sessions on psychedelics · September 15–19, 2026, New Orleans, LA. Compare psychedelics at other meetings →
Tuesday, September 15
Debate · Psychedelics
Psychedelic Therapy After the Executive Order: Now What?
Marcus Capone · Amber Capone · Matthew Zorn · Rakesh Jain · Saundra Jain · Andrew Penn · Charles Raison
Opening-afternoon multidisciplinary panel pairing a patient's lived-experience story with a policy update on how the recent executive order and existing regulatory frameworks may shape near-term clinical use of psychedelic therapies.
Thursday, September 17
Symposium · MasterClass
MasterClass: Unlocking the Doors of Depression: Neuroplastic and Psychedelic Therapies in MDD
Examines glutamatergic and serotonergic neuroplasticity pathways and the evidence base for investigational psychedelic and psychedelic-assisted therapies in major depression.
Friday, September 18
Symposium · MasterClass
MasterClass: GAD Care Reimagined: Current Best Practices and the Emerging Role of Psychedelics
Brittany Albright · Andrew Penn
Pairs a review of current GAD standards of care with the therapeutic rationale and emerging evidence for investigational psychedelic compounds in anxiety.
Symposium · Psychedelics
Psychedelics in Psychiatry: Where the Evidence Stands Today and What Comes Next
Evidence-focused update on psychedelic-assisted therapy trials, regulatory developments, and safety considerations, emphasizing separation of validated data from public enthusiasm.
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5